Skip to main content
Home

Main navigation

  • Home
  • Series
  • People
  • Depts & Colleges
  • Open Education

Main navigation

  • Home
  • Series
  • People
  • Depts & Colleges
  • Open Education

cancer

Big Questions - with Oxford Sparks

'Light' Part 3 - How does sunlight damage DNA?

Once we've received our genetic make-up from our parents our genomes are stable, right? What causes mutations in our DNA as we live and grow, and how do our cells repair damage?
Photo of Radcliffe Camera with Oxford banner

Repairing DNA damage

Dr Ross Chapman studies the molecular events triggered by DNA damage detection, and why defects in these events lead to immune deficiency and cancer in humans.
Photo of Radcliffe Camera with Oxford banner

Targeting drug discovery

The development of new medicines is dependent on the identification of novel drug targets.
Cancer

Repairing DNA damage

Dr Ross Chapman studies the molecular events triggered by DNA damage detection, and why defects in these events lead to immune deficiency and cancer in humans.
Photo of Radcliffe Camera with Oxford banner

Targeting drug discovery

The development of new medicines is dependent on the identification of novel drug targets.
Photo of Radcliffe Camera with Oxford banner

Cleaning up misfolded proteins

Misfolded proteins can either create the loss of a cellular function, or escape degradation, causing aggregation diseases.
Cancer

Cleaning up misfolded proteins

Misfolded proteins can either create the loss of a cellular function, or escape degradation, causing aggregation diseases.
Photo of Radcliffe Camera with Oxford banner

Targeting cancer mechanisms

Professor Robert Gilbert's research focuses on the molecular mechanisms underlying membrane pore formation and cell adhesion.
Cancer

Targeting cancer mechanisms

Professor Robert Gilbert's research focuses on the molecular mechanisms underlying membrane pore formation and cell adhesion.
Surgical Grand Rounds Lectures

Genomic revolution and its impact on prostate cancer care

Professor Ash Tewari talks about the genomics of prostate cancer and the implications for managing high risk disease.
Christmas Science Lectures

Radiotherapy: What is it? How does it work? And how will it change?

Radiotherapy has been going on since 1896, only months after the discovery of X-rays.  We will explore what it is, how it works, and examine the change from X-ray beams to particle guns.
Photo of Radcliffe Camera with Oxford banner

Melanoma

Melanoma or skin cancer is one of the fastest rising cancer types. When identified early, melanoma is relatively easy to cure, but once it starts to metastasise, it becomes very difficult to treat.
Photo of Radcliffe Camera with Oxford banner

Targeting epigenetics to treat cancer

Transcription is a tightly regulated process, where chemical modifications initiate the duplication of genetic material. This epigenetic process is often dysregulated in cancer, but it can be targeted with small molecule inhibitors.
Cancer

Melanoma

Melanoma or skin cancer is one of the fastest rising cancer types. When identified early, melanoma is relatively easy to cure, but once it starts to metastasise, it becomes very difficult to treat.
Cancer

Targeting epigenetics to treat cancer

Transcription is a tightly regulated process, where chemical modifications initiate the duplication of genetic material. This epigenetic process is often dysregulated in cancer, but it can be targeted with small molecule inhibitors.
TORCH | The Oxford Research Centre in the Humanities

Interview with Michael Docherty

We catch up with Cancer Research UK's Director of Digital on fundraising in the digital age.
TORCH | The Oxford Research Centre in the Humanities

Fundraising through Digital

Michael Docherty (Cancer Research UK) on how clicktivists, slacktivists and hacktivists are helping us beat cancer sooner.
Photo of Radcliffe Camera with Oxford banner

Human Cancer Genetics

Dr Gareth Bond, Associate Member of the Ludwig Institute for Cancer Research, studies the influence of genetic variants on the origins, progression and treatment of human cancer.
Cancer

Human Cancer Genetics

Dr Gareth Bond, Associate Member of the Ludwig Institute for Cancer Research, studies the influence of genetic variants on the origins, progression and treatment of human cancer.
Photo of Radcliffe Camera with Oxford banner

Cancer predisposition and evolution

Identifying genes that increase the risk of bowel or other cancers allows us to offer preventative measures, such as removing tumours at an early stage. A better understanding of how and why cancers grow also helps develop improved treatments.

Pagination

  • First page
  • Previous page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Next page
  • Last page

Footer

  • About
  • Accessibility
  • Contribute
  • Copyright
  • Contact
  • Privacy
  • Login
'Oxford Podcasts' X Account @oxfordpodcasts | Upcoming Talks in Oxford | © 2011-2026 The University of Oxford